EGFR and cancer: In the D5 (DAC stage), mTOR signaling (e.g., AKT2 and RPTOR) and EGFR signaling (e.g., EGFR and GSK3B) were overrepresented (Supplementary Fig. 5g), implying the progression of cancer and tumor growth.